Omeros Corp.

Omeros Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
48.56 M
Public Float
39.68 M
Omeros Corp.
Stock Exchange NASDAQ Stock Market
EPS
$2.48
Market Cap
$720.66 M
Shares Outstanding
49.06 M
Public Float
46.09 M

Profile

Address
The Omeros Building
Seattle Washington 98119
United States
Employees -
Website http://www.omeros.com
Updated 07/08/2019
Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Financials

View All
Created with Highcharts 5.0.14Omeros Corp.Net Income. Fiscal year is January-December. All values USD Thousands.39 79639 79673 67373 67375 09675 09666 74566 74553 48153 481126 757126 757201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Omeros Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1 6001 60053953913 50913 50941 61741 61764 82664 82629 86829 868201320142015201620172018020k40k60k80k

Gregory A. Demopulos
Chairman, President & Chief Executive Officer
Rajiv J. Shah
Director